Annotations: name and location {#sec1}
==============================

The availability of genome sequences of a variety of species, the development of high throughput screening methodologies such as DNA microarrays, and the refinement of computational algorithms for searching large databases have all stimulated more and more genome-wide investigations. In turn, the interpretation of the results of such studies yielding large data sets has depended on the annotation of genes, which suggests relationships in terms of subcellular localization, biochemical activity, or connectivity via a metabolic pathway. Most of the annotations in the databases, however, are predicated on two key tenets in the "classical" approach in naming a gene or protein: (a) the assay used in the initial purification of the protein; and (b) localization in a subcellular compartment consistent with expectations.

More recently, it has become evident that many proteins comprise multiple distinct domains and can interact with a bewildering number of other moieties ranging from other polypeptide sequences to carbohydrate and nucleic acid sequences. In addition, members of many different classes of proteins (secreted growth factors, transcription factors, cytoskeletal proteins, and glycolytic enzymes) have been identified in cellular compartments other than their "classical" site of action. In the present essay, we focus on two protein families that have recently been shown to share localization and functional similarities: carbohydrate-binding at the cell surface and RNA processing inside the nucleus.

Two protein families: SR proteins and galectins {#sec2}
===============================================

Splicing factor 2/alternative splicing factor (SF2/ASF) was initially identified as an activity required for constitutive splicing ([@ref34]) and as a factor that could modulate 5′-splice site selection ([@ref18]). SF2/ASF ([@ref19]; [@ref35]), now designated Sfrs1 ([Table I](#tab1){ref-type="table"}), represents the prototype of a family of splicing factors containing the RS domain, rich in arginine and serine dipeptides. Additional RS-domain-containing proteins were identified by a monoclonal antibody (mAb 104) which recognizes a phosphoepitope shared by the SR proteins ([@ref74]). These include spliceosomal component 35 (SC35; Sfrs2), another factor required for spliceosome assembly ([@ref15]). The SR protein family now contains seven "canonical" members, using the criteria described by [@ref46]. In addition to this canonical SR family, other SR-related families have been described, such as non-canonical SR proteins, SR-related proteins, and RS-domain-containing proteins (for recent reviews, see [@ref46]; [@ref61]). In the present essay, we use the name SR protein family to refer to the seven "canonical" SR proteins. Although a common nomenclature and a numbering system has been designated for the seven members of the SR protein family, investigators in the field of splicing have continued, for the most part, using the original name corresponding to each specific SR protein ([Table I](#tab1){ref-type="table"}). All eukaryotes express some SR family member or recognizable SR-like proteins.

###### 

Polypeptide molecular weight and subcellular localization of SR proteins[^a^](#tfn1){ref-type="table-fn"}

  Name              Polypeptide molecular weight (kDa)   Nuclear   Cytoplasmic                         Extracellular
  ----------------- ------------------------------------ --------- ----------------------------------- ---------------
  Sfrs1 (ASF/SF2)   27                                   \+        \+                                  \+
  Sfrs2 (SC35)      24                                   \+        [^b^](#tfn2){ref-type="table-fn"}   \+
  Sfrs3 (SRp20)     18                                   \+        \+                                  
  Sfrs4 (SRp75)     54                                   \+        \+                                  
  Sfrs5 (SRp40)     30                                   \+        \+                                  \+
  Sfrs6 (SRp55)     38                                   \+        \+                                  
  Sfrs7 (9G8)       26                                   \+        \+                                  \+

Blank boxes in the table represent "not known" due to lack of documented evidence.

Unlike the other members of the SR protein family, Sfrs2 does not undergo nucleocytoplasmic shuttling (see text).

The SR proteins exhibit a modular structure ([Figure 1](#fig1){ref-type="fig"}A) with one or two RNA recognition motifs (RRMs) that provide the basis for RNA-binding activity. In cases where it has been analyzed, individual SR proteins exhibit specific yet degenerate RNA-binding specificities ([@ref44], [@ref45]; [@ref58]). The carboxyl terminal RS domain is characterized as being "disordered" ([@ref23]). Nevertheless, this domain participates in either protein--protein or protein--RNA interactions in assembly of the spliceosome, as well as in targeting the polypeptide to the nucleus (see below).

![Diagram illustrating the domain content and organization of the polypeptides of the SR splicing factor family and the galectin family. (**A**) The seven canonical members of the SR protein family are arranged in the order of the common nomenclature, Sfrs1 through Sfrs7. RRM, RNA recognition motif; RS, domain rich in arginine and serine dipeptides. (**B**) The 15 members of the galectin family are classified into three subfamilies, based on the number and arrangement of domains. CRD, carbohydrate recognition domain. Conserved amino acid residues in the CRD are highlighted. The amino terminal domain of galectin-3, the sole representative of the Chimera group, contains a repeating motif rich in proline and glycine residues. The single amino acid code is used; X denotes any amino acid](cwq097fig1){#fig1}

The galectins are a family of carbohydrate-binding proteins that share two key properties: (a) binding affinity for β-galactosides; and (b) conserved sequence elements in the saccharide-binding site ([@ref3]). To date, 15 mammalian galectins have been identified ([Table II](#tab2){ref-type="table"}). Galectins have also been identified in many non-mammalian species, including birds, amphibians, fish, worms, sponges, and fungi. Screening the databases of genomic DNA sequences and expressed sequence tags has revealed additional candidates for membership in the mammalian galectin family, as well as putative galectins in plants and viruses ([@ref7]).

###### 

Polypeptide molecular weight and subcellular localization of galectins[^a^](#tfn3){ref-type="table-fn"}

  Name          Polypeptide molecular weight (kDa)   Nuclear   Cytoplasmic   Extracellular
  ------------- ------------------------------------ --------- ------------- ---------------
  Galectin-1    14                                   \+        \+            \+
  Galectin-2    14                                   \+        \+            
  Galectin-3    30                                   \+        \+            \+
  Galectin-4    36                                   \+        \+            \+
  Galectin-5    16                                             \+            
  Galectin-6    33                                             \+            
  Galectin-7    15                                   \+        \+            \+
  Galectin-8    35                                   \+        \+            \+
  Galectin-9    35                                             \+            \+
  Galectin-10   17                                   \+        \+            \+
  Galectin-11   15                                   \+        \+            \+
  Galectin-12   36                                   \+        \+            
  Galectin-13   16                                   \+        \+            
  Galectin-14   17                                   \+        \+            \+
  Galectin-15   14                                             \+            \+

Blank boxes in the table represent "not known" due to lack of documented evidence.

Each member of the galectin family contains at least one domain of about 130 amino acids; this domain binds to saccharides and is designated the carbohydrate recognition domain (CRD) ([Figure 1](#fig1){ref-type="fig"}B). Based on the number and organization of domains in the polypeptides, the galectins have been classified into subfamilies ([@ref26]): (a) the prototype group contains one domain, the CRD; (b) the chimera group contains a proline (P)- and glycine (G)-rich domain (also about 130 amino acids) fused amino terminal to the CRD; and (c) the tandem repeat group contains two CRDs.

In the amino acid sequence of galectin-3 (Gal3), the sole representative of the chimera group, the P- and G-rich domain is characterized by multiple internal sequence homologies, each of which consists of a nine-residue repeat with a consensus sequence of Pro--Gly--Ala--Tyr--Pro--Gly, followed by three additional amino acids. Differential scanning calorimetry of the murine Gal3 polypeptide yielded distinct transition temperatures for the amino terminal, P- and G-rich domain (\~ 40°C), and the carboxy-terminal CRD (\~ 55°C), both in the full-length polypeptide and as isolated preparations of individual domains ([@ref1]). The lower transition temperature of the P- and G-rich domain of Gal3 suggests a "less-ordered" structure, like the RS domain.

Four properties shared by SR proteins and galectins {#sec3}
===================================================

Binding of carbohydrates {#sec4}
------------------------

Recently, [@ref20] reported that Sfrs1, Sfrs2, Sfrs5, and Sfrs7 are expressed at the cell surface of lung endothelial cells (see below). Even more striking was the observation that these SR proteins exhibited carbohydrate-binding activity. In previous studies, a short peptide (IELLQAR), designated I-peptide, was shown to be a carbohydrate mimicry peptide and inhibited carbohydrate-dependent lung colonization of sialyl Lewis X-expressing B16-FTIII-M cells (B16 melanoma cells transfected with fucosyltransferase 3) in E-selectin and P-selectin doubly deficient mutant mice ([@ref17]; [@ref77]). When a membrane protein fraction from rat lung was subjected to I-peptide affinity chromatography, the four SR splicing factors were isolated and identified by mass spectrometry. Recombinant Sfrs1 bound to B16-FTIII-M cells (expressing the sialyl LeX carbohydrate) but not to parental B16 cells. Thus, it appears that endothelial cells expressing cell surface SR splicing factors were responsible for the carbohydrate-dependent binding and lung colonization of the sialyl LeX-expressing B16-FTIII-M cells.

Using a glycan array, it was determined that Sfrs1 bound a series of fucosylated oligosaccharides, including H-type 1, H-type 2, LeX, LeY, and LeB structures ([@ref20]). Sfrs1 also exhibited strong binding to α-rhamnose (6-deoxy-mannose); this was rationalized in terms of the structural similarity of this saccharide to fucose (6-deoxy-galactose). These results provoke questions and investigations at several levels. First, do other members of the SR protein family also bind carbohydrates? Second, what is the structural basis for the observed carbohydrate-binding activity of Sfrs1? Finally, since it was reported that Sfrs1 requires calcium for binding to saccharides, is there a calcium-dependent CRD as seen in the C-type lectins ([@ref76])?

The carbohydrate-binding specificity of various purified galectins has been studied extensively and interpreted in terms of the three-dimensional structures which have been determined for CRDs derived from galectin-1 (Gal1), galectin-2, Gal3, galectin-7, and galectin-10 (see [@ref39] for an overview). The CRDs all show a highly conserved tight fold, with two anti-parallel β-pleated sheets forming a sandwich-like structure ([@ref55]). Amino acid side chains on one of these sheets form the core carbohydrate-binding site; the highly conserved residues responsible for saccharide-binding include H158, N160, R162, N174, W181, E184, and R186 (residue numbering from the human Gal3 sequence as reported in [@ref60]).

The composite picture derived from ligand binding and structural studies suggests that the binding site is composed of at least four subsites, each of which interacts with a single monosaccharide unit ([@ref38]; [@ref33]; [@ref27]). More recently, this has been refined to six subsites (designated as A, B, C, D, D′, and E) by [@ref63], who conducted a detailed dose--response analysis of the binding of Gal1, galectin-2, and Gal3 to a microarray containing hundreds of structurally diverse glycans. The major and most conserved feature in the interaction of a galectin polypeptide with saccharides is the binding of a galactose residue in subsite C. This includes direct interaction of the monosaccharide with six of the seven most highly conserved amino acid residues listed above. The binding of a second monosaccharide unit in subsite D is also significant inasmuch as there is an approximately 100-fold higher affinity for lactose than for galactose. Subsite D allows for variations such as in lactose (Galβ1-4Glc) versus lactosamine (Galβ1-4GlcNAc). Differences in the specificities of the galectins are often reflected in the preference of subsite D for different monosaccharides. Other fine features of the specificity of galectins can be additionally accounted for by their ability to accommodate different saccharides (Gal, GalNAc, GlcNAc, Fuc, or NeuAc) or aglycone groups (e.g., sulfate) in subsite B, with further extensions in subsite A.

As an example, Gal3 binds type 1 or type 2 Galβ1→3(4)GlcNAc chains, and the affinity for straight-chain polylactosamine structures or complex-type branched glycans is increased over the simple disaccharide. Fucosylation or sialylation of terminal galactose residues or further substitution by (α1→3)-linked Gal or GalNAc does not affect binding or may even enhance it, whereas substitution (occupying subsite D′) of the penultimate GlcNAc residue in subsite D drastically reduces binding. Thus, blood group A, H-type 1, or H-type 2 structures show high affinity, whereas LeA and LeX structures bind poorly. While Gal1 and galectin-2 share some common binding characteristics with Gal3, it is important to note that the study of [@ref63] highlights the fact that, in mechanistic detail, each of the galectins differs in binding to glycans on microarrays and on cell surfaces. These differences provide the basis for unique and/or opposing biological activities.

Cell surface expression and extracellular localization {#sec5}
------------------------------------------------------

In addition to the isolation of Sfrs1, Sfrs2, Sfrs5, and Sfrs7 as carbohydrate-binding receptors, several other lines of evidence are consistent with the notion that SR proteins are expressed at the cell surface of endothelial cells ([@ref20]). First, mice were injected with anti-Sfrs1 antibodies through the tail vein. Lung tissue sections prepared from such mice yielded fluorescent capillaries when visualized with fluorescence-conjugated secondary antibody. In contrast, analysis of similar sections from mice injected with irrelevant primary antibody yielded no fluorescence staining. Second, proteins exposed to the luminal surface of blood vessels of a mouse were labeled using a biotinylation reagent injected through the tail vein ([@ref54]). When the in vivo biotinylated lung endothelial surface proteins were immunoprecipitated with anti-Sfrs1, the precipitated Sfrs polypeptides can be detected by peroxidase-conjugated avidin. Finally, as discussed above, Sfrs1, Sfrs2, Sfrs5, and Sfrs7 bind to the carbohydrate mimic, I-peptide. Mice were injected intravenously, first with anti-Sfrs antibodies and then followed by I-peptide displaying phage particles ([@ref17]). The binding of the I-phage to the lung was inhibited by anti-Sfrs but not by control normal goat immunoglobulin. All of these results indicate that the SR proteins are expressed on the luminal cell surface of lung capillaries.

With the discovery of [@ref20], the SR family of splicing factors joins a surprisingly long and rapidly growing list of diverse proteins that have been reported to exhibit dual localization ([Figure 2](#fig2){ref-type="fig"}A and B), being found in both the extracellular (cell surface and medium) and intracellular (cytoplasm and nucleus) compartments of cells ([@ref2]). The mechanism by which the SR proteins are externalized, however, must be unusual inasmuch as there does not appear to be a signal sequence to direct the polypeptide into the endomembrane pathway for cell surface expression and/or secretion. An unconventional secretion pathway has also been postulated for the galectin family ([@ref31]; [@ref50]), in which 10 of the members are found outside of cells ([Table II](#tab2){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}C) despite the fact that the amino acid sequences of the polypeptides do not exhibit an obvious signal sequence.

![Schematic comparison of the "initial" and the "emerging" views of the localization and activities of the SR splicing factor and the galectin protein families. (**A**) The SR proteins were initially identified as splicing factors in the nucleus. (**B**) It is now known that SR proteins are also found as components of mRNPs in the cytoplasm as well as cell-surface carbohydrate-binding proteins. (**C**) Galectins were initially studied as carbohydrate-binding proteins of the cell surface and extracellular matrix. (**D**) Galectins have now been localized in the nucleus, and at least two members of the family participate in pre-mRNA splicing. The possibility that cell surface galectin serves as a carbohydrate receptor is also raised in this depiction. RRM, RNA recognition motif; RS, domain rich in arginine and serine dipeptides; CRD, carbohydrate recognition domain; CHO, carbohydrate](cwq097fig2){#fig2}

The literature on the galectins has been dominated by studies focused on their activity on the extracellular side (for reviews, see [@ref39] and [@ref53]). The present essay will illustrate three salient features using Gal3 as an example. First, Gal3 binds to oligosaccharide structures on cell surface or extracellular matrix proteins to modulate cell-to-cell or cell-substrate adhesion. For example, Gal3 induces neutrophil adhesion to laminin by bridging the cell surface carbohydrates to the adhesive glycoprotein ([@ref36]). This kind of bridging function may be particularly important in organogenesis. The extracellular matrix protein hensin is responsible for the differentiation of a clonal, intercalated epithelial cell line to form columnar structures and develop specialized apical membrane structures (microvilli) and functions (regulated endocytosis or exocytosis). Upon terminal differentiation, the epithelial cells externalize Gal3, which bundles hensin to maintain polarity in the differentiated state ([@ref25]).

Second, Gal3 binds to saccharide structures on certain cell surface receptors, leading to their cross-linking and activation which, in turn, induces signaling events and physiological responses from within the cell. The binding of Gal3 to CD98 on the T-lymphocyte cell line Jurkat results in the uptake of extracellular Ca^2 +^ ions ([@ref13]). It has been shown that Gal3 binds to CD32 (the low-affinity IgG receptor FcγRII) on peripheral blood mononuclear cells and induces down-regulation of the IL-5 gene ([@ref8]). Gal3 also binds to the high-affinity IgE receptor FcεRI on mast cells and a rat basophilic leukemia cell line, modulating the IgE-dependent activation as assayed by degranulation and serotonin release ([@ref81]).

Finally, Gal3 at the cell surface appears to play a supportive role in endocytosis by binding to cubilin, a \~ 400-kDa membrane protein implicated as the endocytic receptor for a variety of molecules ([@ref9]). Interestingly, cubilin is found only in perforin-containing granules of uterine natural killer cells. By in situ hybridization, cubilin mRNA could be found in the yolk sac epithelium but not in the uterine natural killer cells. These results raise the possibility that yolk sac-derived cubilin is endocytosed by uterine natural killer cells via Gal3.

In the examples cited above to illustrate the three features of the extracellular galectin activity, Gal3 acts as a soluble protein binding to cell surface carbohydrates ([Figure 2](#fig2){ref-type="fig"}C). On the other hand, the results of [@ref20] document SR proteins as carbohydrate-specific receptors, responsible for the sialyl LeX-dependent binding and lung colonization of B16 melanoma cells. Using magnetic glyco-nanoparticles, the binding of specific saccharides to the cell surface of various cell types and tissues has been documented both in vitro and in vivo via magnetic resonance imaging ([@ref66]; [@ref14]). Although the identity of the carbohydrate-binding protein(s) responsible for the recognition of each of the specific glyco-nanoparticle has not been definitively established, the data are consistent with the possibility that cell surface SR splicing factors, along with the well characterized E-selectin, P-selectin, and mannose receptors, could collectively contribute to the observed binding. This, in turn, raises the question whether galectins might be cell-surface carbohydrate receptors as well ([Figure 2](#fig2){ref-type="fig"}D).

Partitioning between the nucleus and cytoplasm {#sec6}
----------------------------------------------

Early immunofluorescence studies localized Sfrs2 to the nucleoplasm ([Table I](#tab1){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}A) as well as to discrete regions in the nucleus, designated as speckles ([@ref15]). More recent studies have shown that all SR protein family members can be found in these speckles ([@ref4]; [@ref59]), which are thought to be sites to which factors involved in transcription and splicing coalesce for storage, recycling, or reactivation during periods of less active transcription (for a review on nuclear speckles, see [@ref78]). Additional studies have shown that SR proteins move to regions of active transcription and can be recruited to nascent mRNPs as RNA polymerase II is elongating the transcript ([@ref47], [@ref48]; [@ref59]). The RS domain (or even a short stretch of RS dipeptides) is sufficient for targeting to the nucleus; this is mediated by transportin-SR, which shows sequence similarity to the nuclear import receptors importin-α and importin-β ([@ref4]; [@ref6]).

With the exception of Sfrs2, the SR splicing factors undergo nucleocytoplasmic shuttling ([@ref5]), binding to nascent, nuclear, and cytoplasmic mRNAs, suggesting a role for SR protein members in the biogenesis and activities of various mRNPs ([@ref59]; [@ref79]). The nuclear export of the SR proteins has been linked to mRNA export due to the interaction between TAP, an RNA export factor, and some members (Sfrs1, 3, 7) of the SR protein family ([@ref28]). Hypophosphorylated Sfrs1 and 7 preferentially bind to TAP, and this form of Sfrs1 can be found associated with mature mRNPs ([@ref29]; [@ref41]). Interestingly, a recent report has implicated arginine methylation of Sfrs1 in the control of its subcellular localization; Sfrs1 mutants that are unable to be methylated and lack positive charge accumulate in the cytoplasm ([@ref62]). In the cytoplasm, the SR proteins have been shown to stimulate translation ([@ref56], [@ref57]), and Sfrs1 has been shown to be polysome-associated ([@ref58]).

Of the 15 galectins identified, 11 have been reported to be in the nucleus and cytoplasm of cells ([Table II](#tab2){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}D). Several distinct activities have been reported for galectins in the cytoplasm, including membrane anchorage of the H-Ras oncogene product by Gal1 ([@ref51]) and anti-apoptotic activity of Gal3 ([@ref73]). This diverse set of subjects has been reviewed ([@ref43]; [@ref42]), and the present essay will focus only on those issues for which there is parallelism with the SR splicing factors.

The nuclear versus cytoplasmic distribution reported for each galectin most likely reflects the specific cell type and experimental conditions (source of cells under study, culture conditions, proliferation status of the cell/culture, or neoplastic transformation). For example, Gal3 has been reported to be exclusively cytoplasmic, predominantly nuclear, or distributed between the two subcellular compartments (for a recent review, see [@ref22]). In fact, Gal3 shuttles between the cytoplasm and nucleus ([@ref11]), and an importin-α/β-mediated nuclear localization signal and an exportin-1-mediated nuclear export signal have been identified on the polypeptide ([@ref12]; [@ref40]; [@ref49]). In contrast to Sfrs1, in which a hypophosphorylated form is preferentially exported ([@ref41]), it is the phosphorylated form of Gal3 that is transported during nuclear export ([@ref65]; [@ref64]). On this basis, there must be exquisite mechanisms by which Gal3 localization, transport, and association with distinct subcellular components are regulated.

Like Sfrs2, Gal1 and Gal3 have been localized in the nucleoplasm and in speckles under fluorescence microscopy and to corresponding structures by electron microscopy ([@ref30]). In fact, double immunofluorescence studies have shown tight co-localization between Gal1, Gal3, and Sfrs2 ([@ref68], [@ref69]). Particularly striking was the observation that Gal3 in the nucleus was dependent on the integrity of ribonucleoprotein complexes ([@ref37]). More recent studies have identified a Gal3-U1 small nuclear ribonucleoprotein (snRNP) complex, which provides a mechanism of incorporation of the galectin onto the pre-mRNA splicing substrate ([@ref21]; see below).

Splicing of pre-mRNA {#sec7}
--------------------

Since its initial discovery, Sfrs1 and the other members of the SR protein family have been investigated intensely in terms of their participation in splicing (for recent reviews, see [@ref46]; [@ref61]; [@ref79]). In contrast, much less work and much less information have been accumulated for the galectins with regard to splicing. We will restrict our discussion of the galectins to Gal1 and Gal3, the two members that have been documented as splicing factors ([@ref10]; [@ref68]). This disparity is opposite the situation with respect to carbohydrate-binding activity, in which much more has been learned regarding the galectins. Nevertheless, there appears to be significant overlap in terms of what we do know regarding the splicing activity of the two protein families ([Table III](#tab3){ref-type="table"}).

###### 

Comparison of selected features in splicing displayed by galectins and SR proteins[^a^](#tfn4){ref-type="table-fn"}

  ACTIVITY                                                                  GALECTIN FAMILY   SFRS FAMILY
  ------------------------------------------------------------------------- ----------------- ----------------
  Members active in pre-mRNA splicing                                       Gal1/Gal3         All
  Depletion abolishes splicing activity                                     Yes               Yes
  Recombinant protein reconstitutes splicing                                Yes               Yes
  Splicing activity redundant with other family members                     Yes               Yes/No
  Protein domain active in reconstitution                                   CRD               intact protein
  Assembled onto spliceosome throughout pathway                             Yes               Yes
  Binds pre-mRNA directly                                                   No                Yes
  Salt concentration that releases protein from spliceosomes                \> 130 mM         \> 250 mM
  Members on separate spliceosomes                                          Yes               No
  Members of endogenous RNP complexes in the absence of pre-mRNA scaffold   Yes               Yes
  Saccharides inhibit splicing activity                                     Yes               
  Carbohydrate-binding site separate from splicing site                     Yes               
  Involved in alternative splicing                                                            Yes

Blank boxes in the table represent "not known" due to lack of documented evidence.

Using cell-free splicing assays, the classic criteria of depletion--reconstitution have established Gal1 and Gal3, as well as all members of the SR family, as required factors in splicing. In general, the SR splicing factors function in defining both the 5′- and 3′-splice sites and bridge factors assembled at both sites to form stable complexes committed to the splicing pathway. Many members of the SR protein family display a redundant function in cell-free assays using standard pre-mRNA substrates ([@ref16]; [@ref75]; [@ref71]). However, individual SR proteins have distinct specificity and efficiency in splicing different pre-mRNA substrates, and SR proteins are known to affect splice site selection in a concentration-dependent manner (see review by [@ref46]).

[Figure 3](#fig3){ref-type="fig"} highlights two important aspects of the association of Gal1/Gal3 and the SR proteins with the splicing machinery. First, members of both protein families are associated with the pre-mRNA substrate from the early commitment complex to the final active C complex (reviewed by [@ref72]; [@ref70]), as depicted on the left side of the figure under splicing complexes. Second, the right side of the figure illustrates the fact that, in the absence of a pre-mRNA scaffold, SR proteins and Gal3 can be found either as free protein or in association with multiple ribonucleoprotein complexes, including complexes containing all five snRNPs ([@ref52]; [@ref21]). This is significant because one mechanism for the incorporation of Gal3 onto the forming spliceosome is through its association with the U1 snRNP, which recognizes the 5′-splice site of the pre-mRNA substrate ([@ref21]).

![Diagram illustrating the association of SR splicing factor(s) and galectin(s) with snRNPs and with the pre-mRNA substrate in the assembly of the spliceosome. The pre-mRNA is shown on the left side as two rectangular exons joined by a single-line intron. The SR proteins, represented by Sfrs, can interact with the pre-mRNA via its RNA recognition motif. Galectin-3 (Gal3) can enter the splicing pathway through its association with U1 snRNP, highlighted at the top on the right side. The unmarked ovals represent other components of the splicing machinery. The left side highlights the fact that Sfrs and Gal3 are associated with the pre-mRNA substrate from the early commitment complex through the active C complex, and the final mature mRNA product. Both Sfrs and Gal3 are found as free polypeptides as well as being associated with multiple snRNPs in larger complexes outside of the spliceosome, as schematically illustrated on the right side](cwq097fig3){#fig3}

[Table III](#tab3){ref-type="table"} also highlights three differences between galectins and the SR proteins. First, both domains of the SR protein interact directly with the pre-mRNA splicing substrate ([@ref24]), whereas it appears that neither Gal1 nor Gal3 binds pre-mRNA directly ([@ref72]). Second, more than one SR family member can coexist on the same spliceosome ([@ref70]), while it appears that Gal1 and Gal3 assemble onto different spliceosomes ([@ref72]). Finally, the stability of the association of each family with spliceosomes is very different in terms of ionic strength. Galectins can be released from spliceosomes at \~ 130 mM salt ([@ref72]), and the SR proteins remain associated even when the salt concentration is 250 mM ([@ref32]; [@ref80]). The significance of this disparate stability is intriguing.

The comparisons between SR proteins and galectins in [Table III](#tab3){ref-type="table"} also pose questions that require future investigations. First, [@ref10] had documented that, in cell-free assays, carbohydrate ligands of galectins inhibit splicing, whereas non-binding saccharides failed to yield the same effect. Do saccharides that bind the SR proteins modulate splicing in the cell-free assay (i.e. are the RNA-binding and carbohydrate-binding activities mutually exclusive for SR proteins)? Moreover, can saccharide ligands of both SR proteins and galectins serve as endogenous splicing regulators in intact cells? Second, site-directed mutants of Gal1, devoid of carbohydrate-binding activity, retained the ability to reconstitute splicing in a galectin-depleted nuclear extract, suggesting that saccharide-binding, per se, is not required for the splicing activity of galectins ([@ref67]). Can the splicing and carbohydrate-binding activities of the SR proteins be similarly dissociated? Third, while SR proteins are known to be involved in splice site selection and alternative splicing, the question remains whether the splicing activity of the galectins is restricted to constitutive splicing or broader in scope to include alternative splicing.

Summary and perspectives {#sec8}
========================

The studies cited in the present review document that two distinct families of proteins share the following four properties: (a) pre-mRNA splicing activity; (b) carbohydrate-binding activity; (c) nuclear localization; and (d) cell surface expression. The SR proteins SF2/ASF and SC35 were so named because they were initially discovered on the basis of their splicing activity and localized to the nucleus ([Figure 2](#fig2){ref-type="fig"}A). The surprise is the recent documentation of their carbohydrate-binding activity at the cell surface ([Figure 2](#fig2){ref-type="fig"}B). In contrast, the galectins were initially purified on the basis of their saccharide-binding activity and cell surface localization ([Figure 2](#fig2){ref-type="fig"}C). The unexpected findings are their association with the spliceosome in the nucleus ([Figure 2](#fig2){ref-type="fig"}D). Why have the carbohydrate-binding domains and cell surface localization properties of the two families been retained? Are the SR proteins lectins disguised as splicing factors, and are the galectins splicing factors masquerading as lectins? Is it just a coincidence that these two conserved families share such properties as carbohydrate-binding, cell surface localization, and splicing activity? Really, what is in a name?
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